Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
New growth hormone secretagogues: C-terminal modified sulfonamide-analogues of NN703B Peschke, B S Hansen
Nephron|January 1, 1988
Lipoproteins and apolipoproteins during the progression of chronic renal diseaseP Grützmacher, W März, B Peschke, et al.
Infusionstherapie Und Transfusionsmedizin|June 1, 1992
[Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening]G Holzberger, S Seidl, B Peschke, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening]G Holzberger, S Seidl, B Peschke, et al.
Transplantation|February 1, 1993
Type III hyperlipoproteinemia acquired by liver transplantationW März, B Peschke, V Ruzicka, et al.
European Journal of Medicinal Chemistry|July 25, 2000
New highly potent dipeptidic growth hormone secretagogues with low molecular weightB Peschke, M Ankersen, T K Hansen, et al.
European Journal of Endocrinology|July 31, 1999
Pharmacological characterisation of a new oral GH secretagogue, NN703B S Hansen, K Raun, K K Nielsen, et al.
Pageof 2